Immunologic self tolerance maintained by T-cell-mediated control of self-reactive T cells: implications for autoimmunity and tumor immunity (Q34374572)

1 August 2017

1 reference

title

Immunologic self tolerance maintained by T-cell-mediated control of self-reactive T cells: implications for autoimmunity and tumor immunity (English)

1 reference

1 August 2017

S Sakaguchi

1 reference

1 August 2017

T Takahashi

1 reference

1 August 2017

S Yamazaki

1 reference

1 August 2017

Y Kuniyasu

1 reference

1 August 2017

M Itoh

1 reference

1 August 2017

N Sakaguchi

1 reference

1 August 2017

J Shimizu

1 reference

1 August 2017

publication date

1 September 2001

1 reference

1 August 2017

published in

Microbes and Infection

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

911-918

1 reference

Tumor antigens recognized by T lymphocytes

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Homeostasis and self-tolerance in the immune system: turning lymphocytes off.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Regulatory T cells: key controllers of immunologic self-tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

A model for developmentally acquired thymus-dependent tolerance to central and peripheral antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Subsets of CD4+T Cells and their Roles in the Induction and Prevention of Autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Regulatory T cells in autoimmmunity*.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Adoptive transfer of autoimmune diabetes and thyroiditis to athymic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Transfusions enriched for W3/25+ helper/inducer T lymphocytes prevent spontaneous diabetes in the BB/W rat

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Restricted expression of p55 interleukin 2 receptor (CD25) on normal T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Anergic T cells as suppressor cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Anergic T cells actively suppress T cell responses via the antigen-presenting cell

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

The Emerging Role of CTLA-4 as an Immune Attenuator

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Induction of anti-self-immunity to cure cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901452-6

1 reference

7 January 2021

10.1016/S1286-4579(01)01452-6

Identifiers

DOI

1 reference

1 August 2017

1 reference